Skip to main content
. 2018 Jul 4;8:10074. doi: 10.1038/s41598-018-28423-9

Table 3.

Antibody association for CTLA-4 +49 G/A in T1D patients

Pos Neg OR (95% CI) P value
ZnT8A
A 225 298 0.84 [0.68, 1.03] 0.09
GG 249 259 1
GA 167 220 0.79 [0.61, 1.03] 0.08
AA 29 39 0.77 [0.46, 1.29] 0.32
GADA
A 372 184 0.89 [0.72, 1.09] 0.26
GG 379 156 1
GA 268 138 0.80 [0.61, 1.05] 0.11
AA 52 23 0.93 [0.55, 1.57] 0.79
IA-2A
A 235 319 0.78 [0.64, 0.95] 0.01**
GG 266 269 1
GA 185 219 0.85 [0.66, 1.11] 0.23
AA 25 50 0.51 [0.30, 0.84] 0.008**
IAA
A 60 175 0.93 [0.66, 1.31] 0.69
GG 63 172 1
GA 48 129 1.02 [0.65, 1.58] 0.94
AA 6 23 0.71 [0.28, 1.83] 0.48

Note: For each autoantibody, the first row indicates the minor allele for which the odds ratio (OR) is estimated (95% confidence intervals (CI) is shown between brackets. For the genotypic association the most common homozygous group was taken as the reference. The association tests include age at T1D onset and duration as covariates. Numbers in parenthesis indicate the frequency of this genotype or allele. Pos, positive; Neg, negative; **P < 0.01.